Regulatory T cells and other lymphocyte subpopulations in patients with melanoma developing interferon-induced thyroiditis during high-dose interferon-α2b treatment-Reference-Cited by-同舟云学术

Regulatory T cells and other lymphocyte subpopulations in patients with melanoma developing interferon-induced thyroiditis during high-dose interferon-α2b treatment

Published:2013-03-12 Issue:4 Volume:78 Page:621-628
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Soldevila Berta,Alonso Núria,Martínez-Arconada Maria J.,Granada Maria L.¹,Boada Aram²,Vallejos Virginia³,Fraile Manuel³,Fernández-Sanmartín Marco A.,Pujol-Borrell Ricardo,Puig-Domingo Manel,Sanmartí Anna,Martínez-Cáceres Eva M.

Affiliation:

1. Department of Clinical Biochemistry; Hospital Universitari Germans Trias i Pujol

2. Department of Dermatology; Hospital Universitari Germans Trias i Pujol

3. Department of Nuclear Medicine; Hospital Universitari Germans Trias i Pujol

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cen.12036/fullpdf

Reference35 articles.

1. Adjuvant therapy of melanoma with interferon: lessons of the past decade;Ascierto;Journal of Translational Medicine,2008

2. White blood cell count: a prognostic factor and possible subset indicator of optimal treatment with low-dose adjuvant interferon in primary melanoma;De la Salmonière;Clinical Cancer Research,2000

3. Prognostic significance of autoimmunity during treatment of melanoma with interferon;Gogas;New England Journal of Medicine,2006

4. Type I interferons and T helper development;Farrar;Immunology Today,2000

5. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons;Pfeffer;Cancer Research,1998

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thyroid dysfunctions secondary to cancer immunotherapy;Journal of Endocrinological Investigation;2017-12-13

2. Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17;Annals of the Rheumatic Diseases;2014-09-30